Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Multi Indocitra Tbk. (MICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Multi Indocitra Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Multi Indocitra Tbk. trades at Rp525 (market cap 312B, 4K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Multi Indocitra Tbk. are close in size by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (7.6K versus 4K). Which is the better fit depends on your goals.
| DGNS | MICE | |
|---|---|---|
Market Cap | 319B | 312B |
Volume | 7.6K | 4K |
Lot | 76 | 40 |
Turnover | 1.74M | 2.1M |
Average Price | 229.21 | 525.75 |
Value | 1.74M | 2.1M |
Indicative Equilibrium Price | 232 | — |
Indicative Equilibrium Volume | 200 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Multi Indocitra Tbk.
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Read more on MICE →
